Type 2 diabetes affects 10.5% of adults globally, projected to rise to 12.2% by 2045, with 90% of cases being Type 2 diabetes
A study revealed that gut microbiome responses to high- and low-carbohydrate diets influence blood sugar and metabolic health
Dysbiosis in the gut microbiome is linked to Type 2 diabetes, affecting carbohydrate metabolism, fat storage, inflammation and glycemic control
Short-chain fatty acids (SCFAs) from gut bacteria reduce inflammation and enhance insulin sensitivity, playing a key role in preventing diabetes and metabolic imbalances
Optimizing gut health through mitochondrial support, healthy carbohydrates and targeted supplementation like Akkermansia muciniphila improves glycemic control and overall metabolic function